The first “WuXi Healthcare Forum” opened at the St. Regis Shanghai Jing’an today, gathering together world-class scientists, alongside innovators, entrepreneurs, and investors. The forum attracts application of more than 5,000 industry leaders from 2,000 enterprises and organizations, spanning 20 countries, bring their collective insights to bare on the global challenges facing healthcare – exploring what breakthroughs have been achieved, the present realities and future possibilities.
Driven by cutting-edge technology, favorable polices and rising venture capital, the global healthcare industry is facing unprecedented opportunities, but also, considerable challenges. The WuXi Healthcare Forum provides a platform to aggregate global expertise and is designed to promote international convergence and cooperation. Through the exchange of knowledge, experience and insights we will empower the continued growth of the healthcare ecosystem.This two-day forum includes 20 sessions, with a central focus on “medicines for global impact” and “the new healthcare ecosystem”. Over 90 guest speakers will deliver cutting-edge insights on global cooperation in the healthcare industry in order to achieve the next disruptive innovation. The agenda addresses the establishment of an innovative ecosystem, the improvement of efficiency in new drug R&D, and the affordability and accessibility of healthcare products.
Alongside the world-class content, the forum features a special CEO roundtable program, which will showcase 200 innovative companies at the precipice of healthcare innovation.
In parallel to the Forum, partners including Huatai Securities, China Renaissance, Fangda Partners, Goldman Sachs, Morgan Stanley and Deloitte will hold several side events, where the participants can exchange their ideas on trends in healthcare development and popular investment strategies.
“We extend our warmest welcome to all our distinguished guests,” said Dr. Ge Li, Chairman of WuXi AppTec Group, “This is a forum that belongs to everyone in the global healthcare ecosystem. It is a platform of knowledge, wisdom, and learning to provide the key points to success, and just as crucially, the lessons we can learn from failures of the past. It is my hope that more people will participate in contributing to the prosperity of the healthcare ecosystem, and we can take a step closer to realizing the shared dream of WuXi, and the whole industry that ‘every drug can be made, and every disease can be treated’.”
About WuXi AppTec Group
WuXi AppTec Group is a leading global pharmaceutical, biopharmaceutical, and medical device open-access capability and technology platform with global operations. As an innovation-driven and customer-focused platform, WuXi AppTec Group provides a broad and integrated portfolio of services to help our worldwide customers and partners shorten the discovery and development time and lower the cost of drug and medical device R&D through cost-effective and efficient solutions. With its industry-leading capabilities such as small molecule drug R&D and manufacturing, biologics R&D and manufacturing, cell therapy and gene therapy R&D and manufacturing, drug R&D and medical device testing, genomics and data platform, in-vitro and clinical diagnostics, WuXi platform is enabling more than 3,000 innovative collaborators from more than 30 countries to bring innovative healthcare products to patients, and to fulfill WuXi’s dream that “every drug can be made and every disease can be treated.”
